DNase I

DNase I

DNase I 詳細

Molecule Name
Deoxyribonuclease 1
分子の別称
DNase I,Deoxyribonuclease-1,Deoxyribonuclease I
Drug Development Progress
治験薬の数1
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
EC:3.1.21.1,Deoxyribonuclease I,Dornase alfa,DNase I, Lysosomal,DNase I,DNL1,DNASE1,Deoxyribonuclease 1,DRNI,Human Urine Deoxyribonuclease I,Deoxyribonuclease-1,EC 3.1.21.1
バックグランド
Serum endocuclease secreted into body fluids by a wide variety of exocrine and endocrine organs. Expressed by non-hematopoietic tissues and preferentially cleaves protein-free DNA (By similarity). Among other functions, seems to be involved in cell death by apoptosis. Binds specifically to G-actin and blocks actin polymerization. Together with DNASE1L3, plays a key role in degrading neutrophil extracellular traps (NETs) (By similarity). NETs are mainly composed of DNA fibers and are released by neutrophils to bind pathogens during inflammation (By similarity).

DNase I 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
repurposed deoxyribonuclease I (Human Microbiology Institute)Clinical
Alzheimer Disease
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Chorionic GonadotropinLDI-200ApprovedAngiogene Pharmaceuticals
Prostatic Neoplasms; Leukemia, Myeloid, Acute; Infertility, Female; Hypogonadism; Cryptorchidism
詳細